
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67316
Pathology
Obstetrics/Gynecology
Radiology
Abnormal Placentation After Caesarean Section: A Retrospective Study
Muacevic Alexander
Adler John R
Kathpalia Sukesh 1
Kshirsagar Shilpa 1
Kulkarni Manasvi 1
Pandey Rakshit 2
Kulkarni Jayshree 1
1 Obstetrics and Gynaecology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, IND
2 Medicine, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, IND
Sukesh Kathpalia sukesh.kathpalia@dpu.edu.in
20 8 2024
8 2024
16 8 e6731617 5 2024
20 8 2024
Copyright © 2024, Kathpalia et al.
2024
Kathpalia et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/255973-abnormal-placentation-after-caesarean-section-a-retrospective-study
Introduction

Caesarean section (CS) is a lifesaving operation; it can have many complications in subsequent pregnancies. Since the uterine wall and cavity are not normal after CS, the implantation and subsequent trophoblastic invasion and placenta formation may be affected. This study was carried out to find out implantation and placental problems encountered in subsequent pregnancies. The spectrum includes placenta accreta, increta, and percreta and is characterized microscopically by a complete or partial absence of decidua and placental adherence to or invasion of the myometrium. The study was performed to find out the complications of CS in subsequent pregnancies and take measures to detect them early and take appropriate action. 

Materials and methods

This retrospective study was carried out at Dr. D.Y. Patil Medical College and Research Centre Pimpri, Dr DY Patil Vidyapeeth, a large tertiary care centre. Many complications like placenta previa, adherent placenta, ectopic pregnancy, obstetrical hysterectomy, etc, the ones directly related to implantation and placentation, were recorded and compared with the literature.

Results and observations

The study was over a period of three years. During this period, there were 10,296 antenatal cases registered; of all the registered cases, 2,544 were cases of post-caesarean pregnancy. There were three cases of tubal ectopic pregnancy, two were diagnosed as the patients complained of amenorrhoea, spotting, and pain abdomen, confirmed on sonography and one was picked up on a routine first-trimester scan. There were two cases of scar ectopic pregnancy. Both the cases were diagnosed as threatened abortion initially and ultrasound confirmed the diagnosis; both were managed medically. Five cases of placenta previa were encountered. There were three cases of morbidly adherent placenta, and two cases underwent obstetrical hysterectomy.

Conclusion

All surgical procedures have become safe, but they all have some complications. Many complications in the next pregnancy after caesarean are life-threatening and dangerous. These complications should be detected early to prevent any catastrophic event.

previous caesarean
scar ectopic
adherent placenta
caesarean scar
ectopic pregnancy
==== Body
pmcIntroduction

Caesarean section (CS) has become a very safe operation due to many reasons like safe and advanced techniques of anaesthesia, improved surgical skills, better understanding of wound healing, asepsis, antibiotics, advanced neonatal care and blood transfusion facilities. Since it is a safe surgery, the doctors and patients both have become very liberal in resorting to this procedure, sometimes on trivial indications including CS on maternal request. The incidence is increasing rapidly and, in some places, it has gone beyond fifty per cent [1-3].

The acceptable incidence of CS is still not clear. At one time, a rate of 10% to 15% was considered to be acceptable; there is no empirical evidence for an optimum percentage [4]. What matters most is that all women who need caesarean sections receive them, and CS should be performed in good faith.

Though the surgery has become safe and common, it is associated with many adverse outcomes: both short term and long term. There can be many complications in subsequent pregnancies [5,6]. Rupture of the uterus, abnormal placentation, ectopic pregnancy, stillbirth, and preterm delivery can occur in future. Since the uterine wall and cavity are not normal after CS, the implantation and subsequent trophoblastic invasion and placental formation may not be normal. A retrospective study was conducted over three years to find out implantation and placental problems encountered in subsequent pregnancies after CS.

Materials and methods

This retrospective study was conducted at Dr. D.Y. Patil Medical College and Research Centre Pimpri, Dr DY Patil Vidyapeeth, a large tertiary care centre. Institutional ethical waiver was obtained as per letter no I.E.S.C./W/51/2024 dated 30 May 2024. Most of the patients were booked but there were some cases who were admitted at the last moment or were referred from peripheral places as the place of study is a tertiary care centre. The complications that were directly related to implantation and placentation were recorded. Their management and outcomes were studied in detail and these observations were compared with the literature available. The complications that were due to abnormal implantation or placentation were included in the study. This was purely a retrospective study and the cases where there was a problem of implantation and subsequent development of trophoblast or placenta were included, whereas all other cases were excluded. The complications which were studied included placenta previa, adherent placenta, ectopic pregnancy, obstetrical hysterectomy, blood transfusion and others if any.

Results

The study was conducted from April 2021 to March 2024; during this period there were 10,296 antenatal cases registered. Of all the registered cases, 2544 were cases of post-caesarean pregnancy, 1,836 had undergone one CS and 708 had undergone two or more CS in the past. The indications were varied; 1257 had undergone emergency CS and 955 had undergone elective CS, the rest 332 were not able to explain the type of CS. All these cases of previous CS were followed up to delivery and discharge from the hospital and the outcomes were noted. All cases encountered during the study period of three years were included. Table 1 details complications related to abnormal implantation or placentation encountered during the period of study.

Table 1 Summary and Demographic Details

S No	Complication	Number	Parity (P)	Mean Age	
1	Ectopic Pregnancy	3	P2, P2, P2	27.3	
2	Scar Ectopic	2	P2, P3	26	
3	Placenta Praevia	5	P2 - 3, P2 - 2	27.2	
4	Adherent Placenta	3	P2, P2 -2	27.6	
5	Hysterectomy	2	P3 -2	31.5	

Ectopic (tubal) pregnancy

There were three cases of tubal ectopic pregnancy; two were diagnosed as the patients complained of amenorrhoea, spotting and pain in the abdomen, confirmed on sonography (Figures 1, 2) and one was picked up on a routine first-trimester scan. One was managed laparoscopically, one was managed by laparotomy and one was managed medically by a single dose of 50 mg methotrexate. No blood transfusion was required and all three made uneventful recovery. All three cases had undergone one previous CS each.

Figure 1 Tubal pregnancy seen on transvaginal sonography

POD:  Pouch of Douglas

Figure 2 Tubal pregnancy seen on transvaginal sonography

Scar ectopic pregnancy

There were two cases of scar ectopic pregnancy (incidence 1/5148); both cases were diagnosed as threatened abortion initially and ultrasound confirmed the diagnosis as the gestational sac (GS) was in the lower uterine segment at the site of the previous CS scar along with increased vascularity (Figures 3, 4). Both cases did not have foetal cardiac activity and they were managed medically by injection of 50 mg methotrexate. Both cases responded well to a single dose and did not require repeated injections. One case had undergone previous two CSs and one had undergone only one section in the past.

Figure 3 Gestational sac in the lower segment

GS: Gestational sac

Figure 4 Scar ectopic pregnancy with surrounding increased vascularity

Placenta previa

Five cases of placenta previa with previous CS were encountered during the study period. Four were anterior placenta previa, and one was posterior. Out of four cases of anterior placenta previa, two were not adherent and other two were adherent. The anterior placenta previa were not adherent and the posterior placenta previa had no difficulty in the repeat section except that bleeding was excessive from the beginning (Figure 5) as it happens in placenta previa cases, especially the anterior placenta previa. Of the two cases of adherent placenta previa as shown in Figure 6, one had undergone one CS in the past without any living issue, she was managed with repeat section and the adherent placenta was removed with difficulty. The second case of adherent placenta previa had undergone two previous CS and had two living children. She was counselled for hysterectomy and she agreed. In this case, the upper segment section was performed followed by an obstetrical hysterectomy (Figure 7). This case had profuse bleeding and was transfused five pints of packed blood cells. Histopathology examination (HPE) confirmed adherent placenta invading the myometrium (Figure 8); villi were observed within the myometrium.

Figure 5 Placenta previa bleeding at the time of incision

Figure 6 Anterior adherent placenta previa on MRI

Figure 7 Hysterectomy specimen showing morbidly adherent placenta previa

Figure 8 Histopathology showing morbidly adherent placenta invading the myometrium (hematoxylin and eosin staining) 10 X magnification

Morbidly adherent placenta

There were three cases of the morbidly adherent placenta (incidence 0.03%); two were in the lower segment as mentioned in the preceding paragraph. The third case had an adherent placenta but in the upper segment which was confirmed antenatally on MRI (Figure 9). She had her first normal delivery and had undergone a section in her second pregnancy. This patient was counselled for an obstetrical hysterectomy. She underwent a lower segment section followed by an obstetrical hysterectomy. Figure 10 shows an adherent placenta and protruding placenta through the serosa. HPE confirmed adherent placenta (Figure 11). She had an uneventful postoperative recovery.

Figure 9 Placental adherence and invasion in the upper segment on MRI

Figure 10 Placenta protruding from serosa

Figure 11 Histopathology confirmed placental adherence and invasion (hematoxylin and eosin staining) 10 X magnification

Obstetrical hysterectomy

There were two cases of obstetrical hysterectomy, and both were performed as a planned procedure after counselling and obtaining consent. All cases of placenta previa were counselled for hysterectomy if required.

Blood transfusion

Blood transfusion was required only in placenta previa cases with or without morbid adhesions. Two were transfused two packed cell volumes each, one was given three and one was transfused five pints. Transfusion was done both during and after surgery.

Others

There were no other specific complications except a case of wound dehiscence which is not related to abnormal implantation or placentation.

Discussion

CS has become a very common operation mainly because of its safety and easy availability. It is considered a safe operation and can save the life of the baby, mother or both. Like all other surgeries, this too has complications: operative, postoperative and long-term complications [2,5-7]. Complications may occur in future pregnancy and labour resulting in increased maternal and neonatal mortality and morbidity [6,8]. Long-term effects of CS such as infertility, pelvic adhesions, and pelvic pain are well known [6].

This study was carried out to find out complications arising due to abnormal implantation or abnormal placentation after previous CS. Only this aspect of the complications was studied. Ectopic pregnancy chances are increased in subsequent pregnancies. The reason for tubal ectopic pregnancy can be conjectured due to some postoperative adhesions which are known to occur after any surgery [7]. Caesarean scar pregnancy (CSP) is a kind of ectopic pregnancy in which the sac is implanted in the earlier CS scar at the anterior wall of the uterus. It was first described in 1978 and since then, the occurrence of CSP has been on the constant rise [8]. The estimated incidence of CSP is from 1:1800 to 1:2216; our incidence (1:5148) was found to be lower. It represents 6% of all ectopic pregnancies in women with at least one lower uterine segment incision. As the incidence of CS is rising the world over, hence the incidence of CSP is also likely to rise [9]. Diagnosis is based on clinical features and confirmation by imaging where the gestational sac is in the lower segment at the site of the previous scar along with increased vascularity [10,11]. CSP is not a very common clinical entity, correct diagnosis at the right time of CSP is crucial because the missed diagnosis or wrong diagnosis may result in dangerous and serious complications like haemorrhage, uterine rupture and even maternal death [12,13]. Low anterior implantation of the placenta is the most commonly seen early ultrasound sign pointing towards a diagnosis of CSP, although its predictive value and accuracy are not high. The treatment of CSP is still controversial and debatable. There are different ways to manage this condition and termination is better and preferred. It can be done by ultrasound-guided suction curettage along with tamponade by Foley’s catheter to prevent excessive haemorrhage [13]. In a study by Birch Petersen et al., multiple methods were suggested to manage CSP [12]. These were resection through transvaginal approach, laparoscopy, and uterine artery embolization [14] in combination with dilatation and curettage with and without hysteroscopy [12]. Hysterectomy too is one of the options; and medical therapy; either local or systemic has been tried [15]. Our two cases were managed by a single dose of 50 mg of methotrexate. Systemic medical therapy where foetal cardiac activity is present should be avoided. It is also mentioned that CSP has a very strong relationship with placenta accreta spectrum (PAS) in case the pregnancy continues. Both CSP and PAS have similar disease pathways. Indeed, it has been mentioned that pathologic findings were almost similar in the two situations.

CSP is likely a forerunner and has the same histopathological features as PAS; the two clinical situations are likely to be a continuum of the same situation with CSP being a diagnosis of the first and early second trimester, and PAS being found out later in pregnancy (second trimester and beyond). Like PAS, the rate of CSP is rising along with CS births and is likely to increase as the rate of CS births increases and as the diagnostic accuracy of imaging for CSP gets better. PAS and CSP; both involve the placenta attaching to or invading the myometrium, almost always in an area of scarring caused by earlier surgery. While PAS is typically a diagnosis made in the second trimester, some specialists and experts believe that ultrasound findings may be there in the first trimester, further confirming the association of PAS with CSP. Differential diagnosis is usually cervical pregnancy; in contrast to CSP, cervical pregnancy will happen in patients with or without having undergone a prior CS [11,16-20], whereas CSP will always have a history of prior one or more CSs.

Adherent placenta is a dangerous and potentially fatal condition which is more likely to develop where a woman has had a past CS; one or more. Its incidence is 0.13% after two CSs and rises markedly to 2.13% after four and then to 6.74% after six or more [20]. The incidence of adherent placenta was 0.03% in our study. Along with this, there is a similar rise of emergency hysterectomies at delivery [21,22]. Population-based incidence of PAS has been reported to be 4.8/10 000. Placenta previa and adherent placenta are more common after CS. PAS consists of placenta accreta, increta and percreta and is recognised histologically by a complete or incomplete absence of uterine decidual lining and placental adherence to or invasion of uterine musculature. It is a major cause of maternal morbidity and mortality worldwide [23,24]. Its incidence, reported mainly by tertiary centres, has recently reached as high as 17-90 per 10, 000 with the rise in the rates of CS deliveries [25,26]. Some studies have been conducted and those studies mentioned PAS rates within a narrower range, from 1.7 to 4.6 per 10,000 deliveries [27,28]. Incidence is higher in tertiary care centres as these centres manage high-risk cases.

It will be prudent to form a classification and stratification of women who are likely to develop PAS which would be an important step as it should help to recognise them during the antenatal period and to decide and optimize their management at the time of delivery [29-32] preferably at a higher centre. Women having both placenta praevia and at least one prior caesarean section have been identified to have a high-risk profile. This combination is associated with PAS in 10-60% of cases depending on the number of previous CS [26]. Placenta accreta happens when the placenta implants too deeply into the uterus. The risk for placenta accreta increases with each CS [33].

The chances of PAS increase when the placenta is implanted in the lower segment, as the uterine wall is thin; more so when the lower segment is scarred after previous CS. One case had a morbidly adherent placenta in the upper segment. How it occurred cannot be found out. Probably the reason could be that the placenta was removed manually which damaged the decidua resulting in the loss of the protective basal layer. It is a known fact that many specialists remove the placenta manually without waiting for spontaneous expulsion. It is our conjecture and there is no method to prove or disprove this hypothesis; it may just be an incidental occurrence [26,34]. It is not only at term that an adherent placenta can create problems; it is potentially dangerous even in the second trimester. Gautam et al. reported a case of placenta accreta in a mid-trimester pregnancy causing post-abortion haemorrhage. The patient had undergone three CSs in the past which had resulted in adherent placenta. The authors stress the importance of suspecting adherent placenta even in mid trimester in patients with a history of previous CS [35].

The study has some limitations as it is a retrospective study and not a comparative one. Detailed demographic data has not been included as the sole purpose of this paper was to study the complications due to abnormal implantation and placental development in cases of previous CS.

Conclusions

Like all surgeries, CS too has some complications: during operation, after operation, late complications, and complications in the next pregnancy and delivery. The study was conducted to find out complications arising from abnormal implantation and placentation.

Implantation and subsequent growth can be affected as the uterine cavity along with its lining is not normal after CS. Most of the complications are life-threatening and dangerous but can be managed effectively, and these should be detected early to prevent catastrophic eventuality. 

The authors acknowledge Mrs. Poonam K Nikam, Central Research Facility for her contribution.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study. Institutional Ethics Subcommittee, Dr. D.Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune issued approval I.E.S.C./W/51/2024 dated 30/05/2024.

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Sukesh Kathpalia, Shilpa Kshirsagar, Manasvi Kulkarni, Rakshit Pandey, Jayshree Kulkarni

Acquisition, analysis, or interpretation of data:  Sukesh Kathpalia, Shilpa Kshirsagar, Manasvi Kulkarni, Rakshit Pandey, Jayshree Kulkarni

Drafting of the manuscript:  Sukesh Kathpalia, Shilpa Kshirsagar, Manasvi Kulkarni, Rakshit Pandey, Jayshree Kulkarni

Critical review of the manuscript for important intellectual content:  Sukesh Kathpalia, Shilpa Kshirsagar, Manasvi Kulkarni, Rakshit Pandey, Jayshree Kulkarni

Supervision:  Sukesh Kathpalia
==== Refs
References

1 Enhanced recovery after caesarean: current and emerging trends Curr Anesthesiol Rep Patel K Zakowski M 136 144 11 2021 33679253
2 Caesarean delivery: counselling issues and complication management Am Fam Physician Jeffrey D Quinlan Quinlan Murphy NJ 178 184 91 2015 https://www.aafp.org/pubs/afp/issues/2015/0201/p178.pdf 25822271
3 Editorial: “stemming the global caesarean section epidemic” Lancet 1279 392 2018 https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(18)32394-8.pdf 30322560
4 Factors influencing the choice of cesarean delivery and their satisfaction among pregnant women attending maternity hospital in Eastern Uttar Pradesh Indian J Comm Health Khan IA Tiwari H Malik N 329 333 35 2023
5 Short-term and long-term effects of caesarean section on the health of women and children Lancet Sandall J Tribe RM Avery L 1349 1357 392 2018 https://pubmed.ncbi.nlm.nih.gov/30322585/ 30322585
6 Relationship between cesarean delivery rate and maternal and neonatal mortality JAMA Molina G Weiser TG Lipsitz SR 2263 2270 314 2015 26624825
7 Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy. A review Am J Obstet Gynecol Timor-Tritsch IE Monteagudo A 14 29 207 2012 22516620
8 The risks of lowering the cesarean-delivery rate N Engl J Med Sachs BP Kobelin C Castro MA Frigoletto F 54 57 340 1999 9878648
9 Methotrexate therapy followed by suction curettage by Foley tamponade for cesarean scar pregnancy Eur J Obstet Gynecol Reprod Biol Jiang T Liu G Huang L Ma H Zhang S 209 211 156 2011 21392878
10 Extreme enhanced myometrial vascularity following cesarean scar pregnancy: a new diagnostic entity J Matern Fetal Neonatal Med Timor-Tritsch IE McDermott WM Monteagudo A 5846 5857 35 2022 http://10.1080/14767058.2021.1897564 33730990
11 Recurrent cesarean scar pregnancy: case series and literature review Ultrasound Obstet Gynecol Timor-Tritsch IE Horwitz G D'Antonio F 121 126 58 2021 33411387
12 Cesarean scar pregnancy: a systematic review of treatment studies Fertil Steril Birch Petersen K Hoffmann E Rifbjerg Larsen C Svarre Nielsen H 958 967 105 2016 26794422
13 Caesarean scar pregnancy: a 10-year experience Aust N Z J Obstet Gynaecol Ko JK Li RH Cheung VY 64 69 55 2015 25350856
14 When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study BMC Pregnancy Childbirth Wang Q Peng H Zhao X Qi X 367 21 2021 33971838
15 Society for Maternal-Fetal Medicine Consult Series #63: cesarean scar ectopic pregnancy Am J Obstet Gynecol Miller R Gyamfi-Bannerman C 0 227 2022
16 New insights into the etiopathology of placenta accreta spectrum Am J Obstet Gynecol Jauniaux E Jurkovic D Hussein AM Burton GJ 384 391 227 2022 35248577
17 Late-diagnosed cesarean scar pregnancy resulting in unexpected placenta accreta spectrum necessitating hysterectomy Fukushima J Med Sci Suzuki N Kyozuka H Fukuda T 156 159 66 2020 32981904
18 Hidden in plain sight: role of residual myometrial thickness to predict outcome of cesarean scar pregnancy Ultrasound Obstet Gynecol Timor-Tritsch IE Monteagudo A Calì G Kaelin Agten A Palacios-Jaraquemada JM D'Antonio F 624 632 62 2023 37266902
19 Development of the utero-placental circulation in cesarean scar pregnancies: a case-control study Am J Obstet Gynecol Jauniaux E Zosmer N De Braud LV Ashoor G Ross J Jurkovic D 399 226 2022
20 Definition and sonographic reporting system for cesarean scar pregnancy in early gestation: modified Delphi method Ultrasound Obstet Gynecol Jordans IP Verberkt C De Leeuw RA 437 449 59 2022 34779085
21 Maternal morbidity associated with multiple repeat cesarean deliveries Obstet Gynecol Silver RM Landon MB Rouse DJ 1226 1232 107 2006 16738145
22 Clinical profiles of placenta accreta spectrum: the PACCRETA population-based study BJOG Kayem G Seco A Beucher G 1646 1655 128 2021 33393174
23 Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease Placenta Jauniaux E Jurkovic D 244 251 33 2012 22284667
24 Prevalence, indications, risk indicators, and outcomes of emergency peripartum hysterectomy worldwide: a systematic review and meta-analysis Obstet Gynecol van den Akker T Brobbel C Dekkers OM Bloemenkamp KW 1281 1294 128 2016 27824773
25 Global epidemiology of use of and disparities in caesarean sections Lancet Boerma T Ronsmans C Melesse DY 1341 1348 392 2018 30322584
26 Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis Am J Obstet Gynecol Jauniaux E Bunce C Grønbeck L Langhoff-Roos J 208 218 221 2019 30716286
27 Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries BJOG Thurn L Lindqvist PG Jakobsson M 1348 1355 123 2016 26227006
28 The Nordic Obstetric Surveillance Study: a study of complete uterine rupture, abnormally invasive placenta, peripartum hysterectomy, and severe blood loss at delivery Acta Obstet Gynecol Scand Colmorn LB Petersen KB Jakobsson M 734 744 94 2015 25828911
29 Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team Am J Obstet Gynecol Erfani H Fox KA Clark SL 337 335 221 2019
30 Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta Am J Obstet Gynecol Collins SL Alemdar B van Beekhuizen HJ 511 526 220 2019 30849356
31 Outcomes of planned compared with urgent deliveries using a multidisciplinary team approach for morbidly adherent placenta Obstet Gynecol Shamshirsaz AA Fox KA Erfani H 234 241 131 2018 29324609
32 The role of centers of excellence with multidisciplinary teams in the management of abnormal invasive placenta Clin Obstet Gynecol Shamshirsaz AA Fox KA Erfani H Belfort MA 841 850 61 2018 30198918
33 A retrospective study of placenta accreta, percreta, and increta in peripartum hysterectomies in a tertiary care institute in northeast India Cureus Dutta S Dey B Chanu S Marbaniang E Sharma N Khonglah Y Raphael V 0 12 2020
34 Placenta accreta--summary of 10 years: a survey of 310 cases Placenta Gielchinsky Y Rojansky N Fasouliotis SJ Ezra Y 210 214 23 2002 11945088
35 Early diagnosis of placenta accreta in case of mid trimester postabortal haemorrhage with previous 3 cesarean sections Indian J Obstet Gynecol Res Gautam A Malik N Jain S 362 365 10 2023
